Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities
MENIN inhibitors are a promising class of targeted oncology drugs in development for acute leukemias and certain solid tumors, but...
